European Lifestars Awards - Celebrating Life Science Leaders’ Post

🚀 LINDERA at LSI Europe '24: Setting the Standard in AI and Healthcare LINDERA will be presenting at #LSIEurope24 this September in Portugal. As pioneers in AI since 2017, our mission is to transform elder care and healthcare with cutting-edge, affordable technology. What Sets Us Apart: 🤖 AI-driven Solutions: We leverage AI to deliver medicine that is not only top-tier but also accessible to everyone, everywhere. Our approach has turned software into a medical device (SaMD), setting new standards in healthcare. 💸 Price as Part of the Solution: In an overburdened elder care system, affordability is crucial. Our AI doesn't just support—it revolutionizes. 👵 From Seniors to AI Pioneers: Learning from the elderly has been akin to how Amazon learned from books. This knowledge has propelled us to lead in medical product innovation globally. 🕺 Innovation in Motion: Our precise 3D-movement analytics and large vision model technologies underscore our role as a hidden champion, offering SDK white label solutions that redefine what's possible in health tech. Join us as we showcase our transformative technologies and contribute to the future of global healthcare. 🔗 For more on the innovation lineup at LSI Europe ‘24, visit their website. #HealthTech #AI #ElderCare #GermanTech

🌟 Countdown to #LSIEurope24: Showcasing AI-Driven Healthcare Innovations in Portugal In Sep, there is the privilege of presenting at LSI Europe '24 in Portugal, a key gathering for technology and innovation. This conference is a platform where LINDERA will highlight how AI is fundamentally changing elder care and healthcare practices. Since 2017, our goal has been to streamline and enhance health assessments using AI. By 2030, we anticipate that manual assessments will be replaced by automated, AI-driven processes that deliver precision and accessibility at scale. Our technology sets new standards in the medical field, making advanced care both affordable and widely available. In Portugal, a growing hub for tech development, let me demonstrate our advancements in AI, including our work in 3D motion analysis and large vision model technologies. These innovations are critical as we continue to improve clinical workflows and patient care across the globe. Join me as we delve into the impact of AI on healthcare at LSI Europe '24. #AIInHealthcare #TechInnovation #HealthTech

A new era of medical education and simulation ( future of Anesthesia and interventional Radiology)

As we hit the #RoadToEurope we’re showcasing the innovators from around the globe who are selected to present at #LSIEurope24. Today we’re showcasing 3 innovators in Germany selected to present at LSI Europe ‘24 in Portugal: 1. Diana Heinrichs — LINDERA → Specializes in app-based 3D motion analysis. With an initial focus on a software as a medical device (SaMD) solution to analyze gait and reduce falls in the elderly, the company has since broadened its platform to include solutions for use in improving fitness, health, and clinical workflow. 2. Claus Jessen — ADVITOS GmbH → Developed ADVOS (ADVanced Organ Support) technology, a multi-organ support technology to improve the survival of the millions of patients that end up in the ICU each year. ADVOS is a single device that enables the simultaneous detoxification of the liver, lungs, and kidneys, in addition to the regulation of blood pH. 3. Jochen Hampe — ConnCons → Integrates connectivity into infusion consumables to create a cloud-to-vessel end-to-end digital solution. The system enables safer, faster and automated therapies with a superior patient experience. First clinical applications are targeted at both center-based and home oncological therapy. We look forward to seeing these innovators take the stage this September 16th - 20th in Portugal. Want to see what other innovators are presenting at LSI Europe ‘24? Head over to our website to see the first 100+ innovators selected to present.

Interesting new IOL Interesting and promising new optic concept

Check out this short video, and please “Like” it on YouTube! We are driven to create the new standard of care for pulmonary embolism therapy, and we hope to spread the word through content such as this (created for our current participation in Medtech Innovator!)

Exciting news in the medical tech world! Philips, renowned for pioneering health technology, has made a leap in treating chronic venous insufficiency (CVI). The first patient has welcomed their innovative Duo Venous Stent System, with FDA's nod of approval. 🥼🩺 Venous outflow obstruction has long been a challenge for 25 million individuals worldwide. Dr. Erin Murphy, armed with the Duo system at Sanger Heart & Vascular Institute, has successfully delivered hope outside trial settings. This duo stent design cleverly addresses both flexibility and compression resistance, a real game-changer in vascular intervention! 💡 Key study, VIVID, reports astounding results - a 90.2% effectiveness in primary patency and a primary safety endpoint at an impressive 98.7%. Participants saw marked improvements in quality of life, a testament to Duo's potential! 📊✅ In the toolboxes of vascular experts, Duo stands out as more than a stent; it's an advancement that pairs seamlessly with IVUS technology. Expect exceptional outcomes and enhanced quality of life, as Philips continues to improve patient care one innovation at a time. 🌟 #Philips #CVI #MedicalInnovation

Do you want to learn more about PRP from the experts? Check out the webinar information below! #prp #exosomes

Qsight Alpha Expands Coverage with the Inclusion of LeMaitre Vascular The newest addition to Qsight Alpha’s Medical Device coverage is LeMaitre Vascular (LMAT). This has been a commonly requested company, and we are excited to be providing insights across the company’s portfolio of peripheral vascular disease products. Looking at the past ten quarters, Qsight has consistently outperformed market expectations and provided accurate insights to drive informed decision-making. During this time, the mean absolute percentage error in Qsight’s projections has been 1.79% With Qsight’s Alpha Hospital Purchasing Data, you will gain visibility into the medical devices and supplies purchased by over 3,500 U.S. facilities. We offer sales projections for 32 publicly traded companies in the MedTech space – all to inform your strategies with predictive insights. Book a demo today: https://lnkd.in/ekEzm4Uu #PredictiveAnalytics #MarketInsights #BusinessForecasting #QsightAlpha

Live from #sessep24 - What a nice surprise to meet Karolina Lipinska-Kowalkow from Laparo Medical Simulators at the SESSEP - Sociedad Española de Simulación Clínica y Seguridad del Paciente congress! We took this opportunity to talk about Laparo's collaboration with Laerdal España and their latest advances. #healthcaresimulation #healthcareinnovation #medicalsimulation